InventionMed Statistics

Total Valuation

InventionMed has a market cap or net worth of PLN 35.49 million. The enterprise value is 38.01 million.

Market Cap	35.49M
Enterprise Value	38.01M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

InventionMed has 202.79 million shares outstanding.

Current Share Class	201.79M
Shares Outstanding	202.79M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	5.61%
Owned by Institutions (%)	n/a
Float	113.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	74.36
PB Ratio	42.99
P/TBV Ratio	49.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.47
EV / Sales	79.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.73

Financial Position

The company has a current ratio of 0.04, with a Debt / Equity ratio of 3.07.

Current Ratio	0.04
Quick Ratio	0.04
Debt / Equity	3.07
Debt / EBITDA	n/a
Debt / FCF	-0.98
Interest Coverage	-1.36

Financial Efficiency

Return on equity (ROE) is -161.39% and return on invested capital (ROIC) is -31.34%.

Return on Equity (ROE)	-161.39%
Return on Assets (ROA)	-4.23%
Return on Invested Capital (ROIC)	-31.34%
Return on Capital Employed (ROCE)	-11.26%
Revenue Per Employee	68,182
Profits Per Employee	-641,335
Employee Count	5
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.05% in the last 52 weeks. The beta is 0.46, so InventionMed's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-22.05%
50-Day Moving Average	0.18
200-Day Moving Average	0.19
Relative Strength Index (RSI)	44.86
Average Volume (20 Days)	230,314

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InventionMed had revenue of PLN 477,271 and -4.49 million in losses. Loss per share was -0.02.

Revenue	477,271
Gross Profit	201,282
Operating Income	-2.61M
Pretax Income	-4.49M
Net Income	-4.49M
EBITDA	-1.76M
EBIT	-2.61M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 16,364 in cash and 2.54 million in debt, giving a net cash position of -2.52 million or -0.01 per share.

Cash & Cash Equivalents	16,364
Total Debt	2.54M
Net Cash	-2.52M
Net Cash Per Share	-0.01
Equity (Book Value)	825,574
Book Value Per Share	0.00
Working Capital	-14.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.39 million and capital expenditures -193,910, giving a free cash flow of -2.58 million.

Operating Cash Flow	-2.39M
Capital Expenditures	-193,910
Free Cash Flow	-2.58M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross Margin	42.17%
Operating Margin	-547.60%
Pretax Margin	-940.63%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

InventionMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-12.65%
FCF Yield	-7.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 6, 2022. It was a forward split with a ratio of 4.

Last Split Date	Sep 6, 2022
Split Type	Forward
Split Ratio	4

Scores

InventionMed has an Altman Z-Score of -1.22 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.22
Piotroski F-Score	2